Funder: Crohn's and Colitis Foundation
Due Dates (Anticipated): August 2026: Request Therapeutics Incubator collaboration agreement for redline by applicant's institution deadline (projected) | October 2026: Full proposal submission deadline, including redlined collaboration agreement (projected)
Funding Amounts: Up to $1,500,000 per project over three years; most funds support CRO-led drug discovery, with some available for academic partner activities.
Summary: Supports academic researchers in developing novel drug therapies for Crohn’s disease and ulcerative colitis by partnering with industry resources for preclinical drug development.
Key Information: This is a forecasted opportunity; all dates are projected and subject to change.